Dr. Sabirah N. Kasule, MD

Dr. Kasule practices at BronxCare Ambulatory Care Network in Bronx, New York.

Dr. Kasule's NPI, 1518493436, was assigned on May 11, 2017. Dr. Kasule graduated from University of Illinois College of Medicine at Chicago in 2017. Dr. Kasule holds New York license 316503.

Dr. Kasule's primary practice is BronxCare Ambulatory Care Network, at 1650 Grand Concourse FL 14, Bronx, NY 10457 in Bronx County. The practice phone is (718) 518-5000.

Dr. Kasule's primary practice is BronxCare Ambulatory Care Network in Bronx, New York. Dr. Kasule is also affiliated with BronxCare Hospital Center. The medical group on file is BronxCare Health System. Dmand AI also links Dr. Kasule to 1 more breast imaging center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kasule practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Kasule's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Kasule's licenses on file in 2 states: New York and Arizona.

CMS data shows 185 Medicare services from Dr. Kasule across 5 procedure codes in 2024, for 93 Medicare patients. Medicare paid $18,183 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 93 Medicare patients who saw Dr. Kasule in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 62% have diabetes. Their average risk score is 3.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kasule's median patient age at 59, with 43% women.

In 2024, Dr. Kasule wrote 3,454 Medicare Part D claims for 136 patients. 65% of them were for generic drugs. CMS names the drug for 2,981 of them, across 73 drugs with 11 or more claims each, at $3,030,992 in total drug cost. In 2023, CMS named 2,109 claims across 63 drugs.

Dr. Kasule accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 14 papers to Dr. Kasule, published from 2018 to 2025. 2022 was the busiest year, with 3. The most frequent topics are West Nile Fever and West Nile virus. Dr. Kasule has published most often in Cureus. Dr. Kasule's most frequent co-authors are Leah M. Grant, MD, Cosmina B. Zeana, MD and Janis E. Blair, MD.

CMS Open Payments shows 10 general payments to Dr. Kasule from 3 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $109.

Dr. Kasule graduated from University of Illinois College of Medicine at Chicago in 2017.